Sign up to our newsletter Subscribe
An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Sign up to our newsletter Subscribe
The 13 April OHE Lunchtime Seminar with Prof William Comanor was attended by about 40 people, hailing from academia, the pharmaceutical and biotechnology industries, consultancies, physicians’ associations, and government. The 13 April OHE Lunchtime Seminar with Prof William Comanor was…
The 13 April OHE Lunchtime Seminar with Prof William Comanor was attended by about 40 people, hailing from academia, the pharmaceutical and biotechnology industries, consultancies, physicians’ associations, and government.
The 13 April OHE Lunchtime Seminar with Prof William Comanor was attended by about 40 people, hailing from academia, the pharmaceutical and biotechnology industries, consultancies, physicians’ associations, and government. The discussion focussed on value-based pricing for prescription medicines in both market and regulated systems, with comparisons of Sweden and the United States.
An error has occurred, please try again later.